Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Transgene Biotek Ltd (NSE: TRABI), ISIN INE773D01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
TRABI last traded at ₹2.50 (-1.57%), with a 52-week range of ₹1.83 to ₹4.19 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 23.64%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 21/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.